About This Research Desk

What Carolina Peptide is

Carolina Peptide sets three research peptides side by side around one theme — soft-tissue and connective-tissue repair: GLOW (a three-peptide combination), KPV (a gut-focused anti-inflammatory tripeptide), and TB-500 (an actin-binding fragment of thymosin beta-4), with TB-500 leading. Each gets its own page; a comparison page lines them up across mechanism, depth of evidence, and regulatory standing; and one shared reference list gathers every citation used across the three.

The organizing discipline here is quantitative wherever the literature allows it: species and sample size, dose or dose-range, and effect size — a percentage, a hazard figure, an mg/kg — rather than adjectives. Where a finding rests on 40 human volunteers and where it rests on a single mouse-colitis model are two very different evidentiary positions, and this desk states which is which every time.

How it is compiled

Two rules shape the pages. First, every factual claim carries a numbered citation — peer-reviewed, PubMed-indexed work with a DOI or PubMed link, collected on the references page — and anything taken from a review rather than a primary study is marked that way. Second, a finding is reported at the strength it was actually measured, never the strength a marketing line would imply: a Phase 1 safety trial in 40 healthy volunteers is called exactly that, not stretched into an efficacy claim, and a blend like GLOW is described as having no blend-level trials at all, however well its separate ingredients are studied. Where the fragment-versus-full-protein question muddies a claim — a recurring problem across the TB-500 literature — the muddle is stated outright, not smoothed away.

What it is not

None of this is a pharmacy, a clinic, or a storefront. Carolina Peptide neither sells nor sources nor brokers GLOW, KPV, TB-500, or their constituents, and holds no affiliate tie to any research-chemical supplier. It names no dose, schedule, or route for any person, and none of the three compounds is FDA-approved for human use. Two of them — TB-500 directly, GLOW by way of it — are barred from tested competition. Anyone with a personal medical question should bring it to a licensed clinician. Corrections to the record — a stale citation, a fresh trial — are welcome through the contact page, though nothing here answers requests for medical advice.